Tuberculosis Elimination in the Era of Coronavirus Disease 2019 (COVID-19): A Moving Target

Navisha Dookie^{1

2}, Nesri Padayatchi^{1

2}, Kogieleum Naidoo^{1

2}

Affiliations

¹ Centre for the AIDS Programme of Research in South Africa, Nelson R. Mandela School of Medicine, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
² South African Medical Research Council Center for the AIDS Programme of Research in South Africa (CAPRISA) HIV-TB Pathogenesis and Treatment Research Unit, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.

Editorial

Navisha Dookie et al. Clin Infect Dis. 2022.

. 2022 Feb 11;74(3):509-510.

doi: 10.1093/cid/ciaa1400.

Navisha Dookie^{1

2}, Nesri Padayatchi^{1

2}, Kogieleum Naidoo^{1

2}

¹ Centre for the AIDS Programme of Research in South Africa, Nelson R. Mandela School of Medicine, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
² South African Medical Research Council Center for the AIDS Programme of Research in South Africa (CAPRISA) HIV-TB Pathogenesis and Treatment Research Unit, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.

No abstract available

Keywords: COVID-19; Tuberculosis.

Comment on

Collateral Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Tuberculosis Control in Jiangsu Province, China.
Liu Q, Lu P, Shen Y, Li C, Wang J, Zhu L, Lu W, Martinez L. Liu Q, et al. Clin Infect Dis. 2021 Aug 2;73(3):542-544. doi: 10.1093/cid/ciaa1289. Clin Infect Dis. 2021. PMID: 32857838 Free PMC article.